<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04968470</url>
  </required_header>
  <id_info>
    <org_study_id>PEC 19-05-001</org_study_id>
    <nct_id>NCT04968470</nct_id>
  </id_info>
  <brief_title>SEBBIN Silicone Gel-filled Testicular Implants</brief_title>
  <official_title>Prospective Observational Study About SEBBIN Silicone Gel-filled Testicular Implants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe SEBBIN</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Groupe SEBBIN</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is part of the clinical evaluation of SEBBIN silicone gel-filled testicular&#xD;
      implants, included in the technical file of the device. The aim of the study is to gather&#xD;
      additional data about the safety and effectiveness of the device.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 16, 2021</start_date>
  <completion_date type="Anticipated">March 2033</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Complication rate</measure>
    <time_frame>At 10 years of follow-up</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Complication</condition>
  <condition>Prosthesis Durability</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The intended target population for the silicone gel-filled testicular implants of Groupe&#xD;
        SEBBIN is any patient (children or adults) with agenesis or testicular atrophy, undescended&#xD;
        testicle, testicular tumour, epididymitis / orchitis, or a trauma, for whom an orchidectomy&#xD;
        with placement of a testicular prosthesis is indicated. Testicular implants are also&#xD;
        indicated for sex reassignment surgeries.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patient is an adult or a child at the time of implant placement with SEBBIN&#xD;
             implant.&#xD;
&#xD;
          -  The patient is candidate to a unilateral or bilateral testicular implant placement&#xD;
             with SEBBIN implant.&#xD;
&#xD;
          -  The patient has been informed of the study, has read the patient information letter&#xD;
             and -provided oral consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The patient has silicone implants somewhere else than in the scrotal sac.&#xD;
&#xD;
          -  The patient was diagnosed with one of the following pathologies:&#xD;
&#xD;
               -  Systemic lupus erythematous, Sjogren syndrome, scleroderma, polymyositis, or any&#xD;
                  other connective tissue disease.&#xD;
&#xD;
               -  Rheumatoid arthritis, crystalline arthritis, infectious arthritis,&#xD;
                  spondyloarthropathies, or any other inflammatory arthritic disease.&#xD;
&#xD;
               -  Arthritis, fibromyalgia, chronic fatigue syndrome, or any other mechanic or&#xD;
                  degenerative non-inflammatory rheumatic disease.&#xD;
&#xD;
          -  The patient has a pathology that could delay healing.&#xD;
&#xD;
          -  Custom-designed implants are used for surgery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Groupe SEBBIN</name>
      <address>
        <city>Boissy l'Aillerie</city>
        <zip>95651</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>St√©phane Piris, MS</last_name>
      <phone>+33 1 34 42 13 28</phone>
      <email>stephane.piris@sebbin.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 6, 2021</study_first_submitted>
  <study_first_submitted_qc>July 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 20, 2021</study_first_posted>
  <last_update_submitted>July 19, 2021</last_update_submitted>
  <last_update_submitted_qc>July 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prosthesis Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

